ArticleThe Lancet regional health. Europe2021
A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021.
Article in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed.
- Trends in socio-demographic disparities in COVID-19 vaccine uptake by vaccine dose and time after the introduction of COVID-19 vaccination in Israel: epidemiological and policy analysis study.Israel journal of health policy research · 2026Article
- Impact of Vaccination-Differentiated Public Health and Social Measures on Vaccine Uptake Among the Vaccine Hesitant.AJPM focus · 2026Article
- Operating in recurrent crises: a qualitative study of decision-making and unintended consequences in a peripheral hospital.Frontiers in public health · 2026Article
- Association of Inhaled Corticosteroid Use with COVID-19 Severity and Hospitalization in Patients With and Without Respiratory Disease.Journal of aerosol medicine and pulmonary drug delivery · 2025Article
- Spatial and Ethno-national Health Inequalities: Health and Mortality Gaps between Palestinians and Jews in Israel.Journal of health and social behavior · 2025Article
- Changes in long-term employment and income following COVID-19 (SARS-CoV-2) infection among Jewish and Arab populations in Israel.BMC public health · 2025Article
- Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population.Human vaccines & immunotherapeutics · 2024Article
- Impact of the COVID-19 pandemic on acute cardiology and neurology services in a secondary peripheral hospital.Scientific reports · 2024Article
- Motives for Vaccination Against COVID-19 Among the Ultra-orthodox Jewish Community in Israel.Journal of religion and health · 2024Article
- Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups.Infectious diseases and therapy · 2024Article
- Exploring the Big Data Paradox for various estimands using vaccination data from the global COVID-19 Trends and Impact Survey (CTIS).Science advances · 2024Article
- Associations of the COVID-19 burden and various comorbidities of different ethnic groups in Israel: a cross-sectional study.Clinical and experimental medicine · 2023Article
- Socioeconomic disparities and concentration of the spread of the COVID-19 pandemic in the province of Quebec, Canada.BMC public health · 2023Article
- The COVID-19 Israeli tapestry: the intersectionality health equity challenge.Israel journal of health policy research · 2023Article
- COVID-19 vaccine compliance in adolescents with attention-deficit/hyperactivity disorder.International journal of psychiatry in medicine · 2023Article
- Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study.The Lancet. Infectious diseases · 2023Observational
- Review of Israel's action and response during the COVID-19 pandemic and tabletop exercise for the evaluation of readiness and resilience-lessons learned 2020-2021.Frontiers in public health · 2023Review
- Policy Disparities Between Singapore and Israel in Response to the First Omicron Wave.Risk management and healthcare policy · 2023Article
- COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.Vaccine · 2022Article
- Association of Household Deprivation, Comorbidities, and COVID-19 Hospitalization in Children in Germany, January 2020 to July 2021.JAMA network open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocial inequalities affect the COVID-19 burden and vaccine uptake. The aim of this study was to explore inequalities in the incidence and mortality rate of SARS-CoV-2 infection and vaccine uptake in various sociodemographic and population group strata in Israel.
methodsWe analysed nationwide publicly available, aggregated data on PCR-confirmed SARS-CoV-2 infections and COVID-19 deaths between March 2020 and February 2021, as well as the first three months of COVID-19 immunisation according to sociodemographics, including population group and residential socioeconomic status (SES). We computed incidence and mortality rates of COVID-19. Comparisons between towns with predominantly Arab, ultra-Orthodox Jewish (the minorities), general Jewish populations, and according to SES, were conducted using generalised linear models with negative binomial distribution.
findingsOverall, 774,030 individuals had SARS-CoV-2 infection (cumulative incidence 84•5 per 1,000 persons) and 5687 COVID-19 patients had died (mortality rate 62•8 per 100,000 persons). The highest mortality rate was found amongst the elderly. Most (>75%) individuals aged 60 years or above have been vaccinated with BNT162b2 vaccine. The risk of SARS-CoV-2 infection was higher in towns with predominantly Arab and ultra-Orthodox Jewish populations than in the general Jewish population, and in low SES communities. COVID-19 mortality rate was highest amongst Arabs. Conversely, vaccine uptake was lower amongst Arab and ultra-Orthodox Jewish populations and low SES communities.
interpretationEthnic and religious minorities and low SES communities experience substantial COVID-19 burden, and have lower vaccine uptake, even in a society with universal accessibility to healthcare. Quantifying these inequalities is fundamental towards reducing these gaps, which imposes a designated apportion of resources to adequately control the pandemic.
fundingNo external funding was available for this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.